The COVID-19 pandemic has shown the world the importance of science and biotech breakthroughs—and in the coming weeks and months, we’ll be working hard to change the dialogue about science in the country.
That’s why we’re launching the I am BIO campaign. This campaign will show how biotechnology innovation is leading the charge to get the world back on track and put a face to biotech by showing the hidden heroes in our labs.
We start by showcasing researchers at Merck and IMV, a high school student finding a way to reuse gray water for irrigation, and a seventh grader who did a research project on video games and depression and plans to become a vet.
Who we’ll feature: people who are making an impact on society with science, as well as those whose lives have been changed because of scientific breakthroughs.
Who we’ll share them with: patients, consumers, lawmakers, media, and even our critics, so everyone can understand how biotech employees are innovators who are changing the world.
But we need YOU to share your story! We developed an easy-to-use app to allow Apple and Android users to record short videos and send them to us. From there, our team will edit the video, work with you on changes, and distribute them. (And don’t worry, you’ll be able to review it before it goes public!)
Visit www.bio.org/iambio to learn more and share your story!
More Health Care News:
Axios: Coronavirus accelerates a new age of diagnostics
“In response to COVID-19, a number of researchers and startups are pushing new diagnostic technologies that take advantage of cheaper and quicker genetic sequencing to provide far more accurate and rapid intelligence on just where COVID-19 is, and where it might be going.”
Reuters: Abbvie strikes partnership to develop COVID-19 antibody therapy
“The human antibody, 47D11, was discovered by Utrecht University, Erasmus Medical Center and Harbor BioMed. AbbVie will support through the preclinical phase, as well as prepare for later stage preclinical and clinical development work.”
STAT News: Longtime executive Tony Coles on biotech, racism, and opportunities for change
“Coles is chairman and CEO of Cerevel Therapeutics. He’s also founder and chairman of Yumanity Therapeutics.”